Cytokinetics (CYTK.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec24

Squarepoint Ops LLC Reduced Stake in Cell Therapeutics

10:08

Dec23

Cellular Dynamics Director Wendell Wierenga Reports Disposal of Common Stock

21:14

Dec22

Cardio Dynamics Approved by FDA to Launch MYQORZO Tablets for oHCM

11:43

Barclays Analyst Maintains Buy Rating on Celldyn

10:11

NMPA Approves Cytokinetics' Aficamten Tablets for Marketing

06:51

Dec19

Cytokinetics Incorporated's MYQORZO™ (aficamten) Receives FDA Approval

21:00

Schedules & Filings

Schedules

Filings

Nov5

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 1.936 M, Net Income -306.18 M, EPS -2.5518

Aug7

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 66.77 M, Net Income -134.37 M, EPS -1.1248

May6

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 1.579 M, Net Income -161.38 M, EPS -1.3618

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change